When are topical calcineurin inhibitors recommended for atopic dermatitis?

Atopic dermatitis causes inflamed, itchy, dry skin and often follows a relapsing pattern. Topical calcineurin inhibitors reduce immune activity in the skin and do not thin the skin in the way prolonged topical steroid use can. A clinician may select them for delicate areas such as the face, eyelids, neck, or skin folds, or when eczema returns in the same place. They can also be used as part of a plan to control repeated flares. The choice depends on age, location, severity, infection risk, and previous treatment response.

Apply a thin layer exactly as prescribed to active or planned treatment areas, then wash your hands unless they are being treated. Moisturiser remains central to eczema care; use it as directed and keep soaps, fragrances, and other known irritants away from the skin. A short-lived warm or stinging sensation can occur when treatment starts. Tell your clinician if discomfort persists, the rash worsens, or blisters, crusting, or oozing appear. Do not apply it to infected skin unless your clinician has given specific instructions.

Get prompt medical advice for rapidly worsening redness, painful blisters, spreading crusts, fever, or feeling unwell, as these can signal infection or another problem. Arrange review when itching prevents sleep, flares keep returning despite the plan, or treatment causes ongoing irritation. A clinician may need to check triggers, infection, or another diagnosis.

Ask which areas need the medicine, whether it is for a flare or prevention, and how it should be combined with moisturiser or another prescription. Confirm what burning is expected and when the plan should be reviewed.